Compare MDCX & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDCX | GNTA |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | Italy |
| Employees | 16 | 13 |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.6M | 19.9M |
| IPO Year | N/A | N/A |
| Metric | MDCX | GNTA |
|---|---|---|
| Price | $0.42 | $1.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 263.6K |
| Earning Date | 05-11-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $0.55 |
| 52 Week High | $3.69 | $10.00 |
| Indicator | MDCX | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 54.32 |
| Support Level | $0.38 | $1.31 |
| Resistance Level | $0.52 | $2.12 |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 55.92 | 21.95 |
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.